Chemomab Therapeutics Ltd. - CMMB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$627K
QoQ value delta ($000)
+$18K (+2.96%)
Implied price effect (QoQ)
-1.57%
Shares
Total shares
397,301
QoQ shares delta
+17,468 (+4.6%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CMMB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 3 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 154 95,311 0.0%
ADAR1 Capital Management, LLC 129 80,000 0.01%
KESTRA PRIVATE WEALTH SERVICES, LLC 99 61,710 0.0%
Ikarian Capital, LLC 83 51,793 0.01%
RHUMBLINE ADVISERS 49 30,529 0.0%
XTX Topco Ltd 25 15,987 0.0%
Philadelphia Investment Partners, LLC 24 15,000 0.01%
Lido Advisors, LLC 23 14,341 0.0%
SmartHarvest Portfolios, LLC 15 13,031 0.01%
BNP PARIBAS FINANCIAL MARKETS 11 6,805 0.0%
GAMMA Investing LLC 10 9,181 0.0%
MORGAN STANLEY 5 3,575 0.0%
SBI Securities Co., Ltd. 0 30 0.0%
Caitong International Asset Management Co., Ltd 0 8 0.0%